The abundance of clinical trials evaluating survival and treatment outcomes in women with breast cancer has resulted in a paradigm shift to more refined surgical treatment parameters and decreased the number of additional surgeries, according to researchers with Memorial Sloan-Kettering Cancer Center in New York, NY, but the ability of surgery to cure breast cancer remains unchanged. The researchers presented the results of their analyses on Wednesday, December 7, during the San Antonio Breast Cancer Symposium.
Women treated with accelerated partial breast irradiation (APBI) reported a significantly better quality of life (QOL) compared to women treated with whole breast irradiation (WBI), a group of Italian researchers has found. They presented their results on Wednesday, December 7, at the San Antonio Breast Cancer Symposium.
A group of British researchers has found that with only minimal changes in clinical parameters because of a lack of perfect correlation between pathologists’ results, there is a significant difference in the 10-year predicted mortality on Adjuvant! Online, a breast cancer risk assessment tool.
Since ONS and the Oncology Nursing Certification Corporation conducted the first role delineation study in 2011, the oncology nurse navigator role has continued to change. Cancer care has evolved, and focus on care coordination has increased to improve quality and reduce costs.
A number of non-stem cell therapies, including cellular vaccines and chimeric antigen receptor (CAR) T cells, are offered to cancer centers. “Demand is growing, with several CAR products heading for imminent U.S. Food and Drug Administration approval,” said Sarah Nikiforow, MD, PhD, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School in Boston, MA.
The original Tamoxifen Exemestane Adjuvant Multinational (TEAM) study found no significant differences for disease free survival (DFS) and overall survival (OS) at five years between exemestane monotherapy and sequential treatment (tamoxifen followed by exemestane), but there is still no universal agreement on optimal endocrine therapy.
The 2016 presidential race was one for the record books. This cycle saw two diametrically opposed candidates, in both style and ideology. They each represented a large segment of the American electorate and wanted to take the country in very different directions. But now it is over, and we can all go back to other endeavors. Right?
You have a patient with cancer who is participating in a clinical trial. The patient has just been told that the trial has been placed on a clinical hold. What does that mean? What should you say to your patient?
In October 2016, the Centers for Disease Control and Prevention (CDC) issued a recommendation that adolescents aged 9–14 need only two doses of the human papillomavirus vaccine at least six months apart, rather than the previously recommended three doses, to achieve immunity.
